Search Results for keywords:"Medical Research"

Found 1 results
Skip to main content

Search Results: keywords:"Medical Research"

  • Type:Notice
    Citation:86 FR 11328
    Reading Time:about 2 minutes

    The Drug Enforcement Administration (DEA) has received an application from AJC Industries, Inc. to become a registered bulk manufacturer of marihuana, a Schedule I controlled substance, for scientific and medical research. This notice allows current registered manufacturers and other applicants to submit comments or objections by April 26, 2021. The DEA will evaluate the application to ensure compliance with legal and regulatory standards and to prevent misuse. Interested parties need to reference Docket No. DEA-797 when submitting their feedback to the DEA's office in Springfield, Virginia.

    Simple Explanation

    The DEA got a request from a company to make a lot of marihuana for research, and they want to know what people think about it. People can say what they think until April 26, 2021, and the DEA will check if everything is safe and follows the rules.